Anti-atrial Fibrillatory Versus Proarrhythmic Potentials of Amiodarone: A New Protocol for Safety Evaluation In Vivo
Autor: | Yuji Nakamura, Suchitra Matsukura, Takeshi Wada, Hiroko Izumi-Nakaseko, Kentaro Ando, Xin Cao, Atsushi Sugiyama |
---|---|
Rok vydání: | 2016 |
Předmět: |
Male
0301 basic medicine medicine.medical_specialty Time Factors Refractory Period Electrophysiological Benign early repolarization Action Potentials Amiodarone Blood Pressure 030204 cardiovascular system & hematology Toxicology Risk Assessment QT interval Electrocardiography 03 medical and health sciences Dogs 0302 clinical medicine Heart Rate Torsades de Pointes Internal medicine Atrial Fibrillation medicine Animals Repolarization Molecular Biology Dose-Response Relationship Drug Atrium (architecture) business.industry Cardiac Pacing Artificial Effective refractory period Amiodarone Hydrochloride Atrial fibrillation medicine.disease Disease Models Animal 030104 developmental biology Anesthesia Cardiology Female Cardiology and Cardiovascular Medicine business Anti-Arrhythmia Agents medicine.drug |
Zdroj: | Cardiovascular Toxicology. 17:157-162 |
ISSN: | 1559-0259 1530-7905 |
DOI: | 10.1007/s12012-016-9369-8 |
Popis: | Anti-atrial fibrillatory and proarrhythmic potentials of amiodarone were simultaneously analyzed by using the halothane-anesthetized beagle dogs (n = 4) in order to begin to prepare standard protocol for clarifying both efficacy and adverse effects of anti-atrial fibrillatory drugs. Intravenous administration of 0.3 mg/kg of amiodarone hydrochloride decreased the heart rate and mean blood pressure. Additional administration of 3 mg/kg of amiodarone hydrochloride prolonged the QT interval besides the effects observed by the low dose, whereas it showed 1.6 times larger prolongation in the effective refractory period of the atrium than that of the ventricle, which may explain its clinical efficacy against atrial arrhythmias. However, no significant change was detected by either dose in the early repolarization assessed by corrected J–T peak or the late repolarization done by T peak–T end in the electrocardiogram, although the former tended to be shortened and the reverse was true for the latter. Lack of prolongation in the early repolarization will make it feasible to better understand why amiodarone lacks proarrhythmic potential in spite of the QT-interval prolongation. Thus, these results of amiodarone obtained by current protocol may become a guidance on assessing efficacy and adverse effects of new anti-atrial fibrillatory drugs in vivo. |
Databáze: | OpenAIRE |
Externí odkaz: |